Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98,279 | 113,959 | 126,306 | 138,909 | 98,894 |
| Receivables | 2,619 | 2,715 | 2,097 | 4,864 | 3,942 |
| Other current assets | 1,662 | 3,269 | 3,676 | 4,328 | 3,776 |
| TOTAL | $102,560 | $119,943 | $132,079 | $148,101 | $106,612 |
| Non-Current Assets | |||||
| PPE Net | 4,352 | 4,563 | 4,702 | 4,760 | 3,899 |
| Intangibles | 43,496 | 43,549 | 43,602 | 43,655 | 43,708 |
| Other Non-Current Assets | 2,474 | 2,472 | 2,471 | 2,470 | 2,718 |
| TOTAL | $50,322 | $50,584 | $50,775 | $50,885 | $50,325 |
| Total Assets | $152,882 | $170,527 | $182,854 | $198,986 | $156,937 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,839 | 1,241 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,116 | 1,132 | 971 | 567 | 1,100 |
| Accrued Expenses | 10,104 | 14,106 | 12,705 | 15,790 | 12,696 |
| Other current liabilities | N/A | N/A | 677 | N/A | 26 |
| TOTAL | $13,059 | $16,479 | $14,353 | $16,357 | $13,822 |
| Non-Current Liabilities | |||||
| Long Term Debt | 47,786 | 48,322 | 48,850 | 49,453 | N/A |
| Other Non-Current Liabilities | 18,947 | 18,166 | 17,386 | 15,419 | 20,906 |
| TOTAL | $79,743 | $79,498 | $79,246 | $77,867 | $32,084 |
| Total Liabilities | $92,802 | $95,977 | $93,599 | $94,224 | $45,906 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,270 | 70,270 | 70,225 | 70,190 | 70,051 |
| Common Shares | 92 | 92 | 92 | 92 | 91 |
| Retained earnings | -538,921 | -523,569 | -506,933 | -490,573 | -483,369 |
| Other shareholders' equity | 225 | 205 | 192 | 174 | 330 |
| TOTAL | $60,080 | $74,550 | $89,255 | $104,762 | $111,031 |
| Total Liabilities And Equity | $152,882 | $170,527 | $182,854 | $198,986 | $156,937 |